250 related articles for article (PubMed ID: 28268799)
1. First steps to creating a platform for high throughput simulation of TTFields.
Hershkovich HS; Bomzon Z; Wenger C; Urman N; Chaudhry A; Garcia-Carracedo D; Kirson ED; Weinberg U; Wassermann Y; Palti Y
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2357-2360. PubMed ID: 28268799
[TBL] [Abstract][Full Text] [Related]
2. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.
Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR
IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870
[TBL] [Abstract][Full Text] [Related]
3. The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study.
Wenger C; Salvador R; Basser PJ; Miranda PC
Phys Med Biol; 2015 Sep; 60(18):7339-57. PubMed ID: 26350296
[TBL] [Abstract][Full Text] [Related]
4. Simplified realistic human head model for simulating Tumor Treating Fields (TTFields).
Wenger C; Bomzon Z; Salvador R; Basser PJ; Miranda PC
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():5664-5667. PubMed ID: 28269540
[TBL] [Abstract][Full Text] [Related]
5. Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study.
Korshoej AR; Hansen FL; Thielscher A; von Oettingen GB; Sørensen JCH
PLoS One; 2017; 12(6):e0179214. PubMed ID: 28604803
[TBL] [Abstract][Full Text] [Related]
6. Modelling Tumor Treating Fields for the treatment of lung-based tumors.
Bomzon Z; Urman N; Wenger C; Giladi M; Weinberg U; Wasserman Y; Kirson ED; Miranda PC; Palti Y
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():6888-91. PubMed ID: 26737876
[TBL] [Abstract][Full Text] [Related]
7. What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
Ornelas AS; Porter AB; Sharma A; Knox MG; Marks LA; Wingerchuk DM; O'Carroll CB
Neurologist; 2019 Mar; 24(2):71-73. PubMed ID: 30817495
[TBL] [Abstract][Full Text] [Related]
8. Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy.
Pohling C; Nguyen H; Chang E; Schubert KE; Nie Y; Bashkirov V; Yamamoto V; Zeng Y; Stupp R; Schulte RW; Patel CB
Bioelectrochemistry; 2023 Feb; 149():108287. PubMed ID: 36306728
[TBL] [Abstract][Full Text] [Related]
9. [Tumor treating fields in cancer treatment in Denmark].
Korshøj AR; Lukacova S; Mikic N; Cortnum SOS; Lassen-Ramshad Y; Guldberg TL; Severinsen KE; Thielscher A; Poulsen FR; Sørensen JCH; Oettingen GBV
Ugeskr Laeger; 2019 Oct; 181(20A):. PubMed ID: 31610842
[TBL] [Abstract][Full Text] [Related]
10. [Tumor treating fields in cancer treatment in Denmark].
Korshøj AR; Lukacova S; Mikic N; Stigaard Cortnum SO; Lassen-Ramshad Y; Guldberg TL; Severinsen KE; Thielscher A; Poulsen FR; Hedemann Sørensen JC; von Oettingen GB
Ugeskr Laeger; 2019 Jan; 181(5):. PubMed ID: 30722819
[TBL] [Abstract][Full Text] [Related]
11. Tumour treating fields therapy for glioblastoma: current advances and future directions.
Rominiyi O; Vanderlinden A; Clenton SJ; Bridgewater C; Al-Tamimi Y; Collis SJ
Br J Cancer; 2021 Feb; 124(4):697-709. PubMed ID: 33144698
[TBL] [Abstract][Full Text] [Related]
12. Rationale and Background on Tumor-Treating Fields for Glioblastoma.
Schwartz MA; Onuselogu L
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S20-4. PubMed ID: 27668387
[TBL] [Abstract][Full Text] [Related]
13. The dielectric properties of skin and their influence on the delivery of tumor treating fields to the torso: a study combining in vivo measurements with numerical simulations.
Hershkovich HS; Urman N; Yesharim O; Naveh A; Bomzon Z
Phys Med Biol; 2019 Sep; 64(18):185014. PubMed ID: 31323651
[TBL] [Abstract][Full Text] [Related]
14. Computed modeling of alternating electric fields therapy for recurrent glioblastoma.
Lok E; Hua V; Wong ET
Cancer Med; 2015 Nov; 4(11):1697-9. PubMed ID: 26311253
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma.
Riley MM; San P; Lok E; Swanson KD; Wong ET
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058901
[TBL] [Abstract][Full Text] [Related]
16. Optimization of tumor treating fields using singular value decomposition and minimization of field anisotropy.
Korshoej AR; Sørensen JCH; von Oettingen G; Poulsen FR; Thielscher A
Phys Med Biol; 2019 Feb; 64(4):04NT03. PubMed ID: 30641498
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy.
Saria MG; Kesari S
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S9-S13. PubMed ID: 27668388
[TBL] [Abstract][Full Text] [Related]
18. Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy.
Jo Y; Kim EH; Sai S; Kim JS; Cho JM; Kim H; Baek JH; Kim JY; Hwang SG; Yoon M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469352
[TBL] [Abstract][Full Text] [Related]
19. Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
Shi W; Blumenthal DT; Oberheim Bush NA; Kebir S; Lukas RV; Muragaki Y; Zhu JJ; Glas M
J Neurooncol; 2020 Jul; 148(3):489-500. PubMed ID: 32535723
[TBL] [Abstract][Full Text] [Related]
20. Tumor treating fields: a new frontier in cancer therapy.
Davies AM; Weinberg U; Palti Y
Ann N Y Acad Sci; 2013 Jul; 1291():86-95. PubMed ID: 23659608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
